Articles tagged with “auto-substitution”

Immgolis: First Interchangeable Biosimilar to Simponi

Analyze the FDA approval of Immgolis (golimumab-sldi), the first interchangeable Simponi biosimilar. Learn how auto-substitution impacts rheumatology care.

45 min read

5/6/2026

immgolis golimumab-sldi simponi biosimilar interchangeable biosimilar auto-substitution rheumatology tnf inhibitors